IGFBP-3/IGFBP-3 receptor system as an anti-tumor and anti-metastatic signaling in cancer

Q Cai, M Dozmorov, Y Oh - Cells, 2020 - mdpi.com
Insulin-like growth factor binding protein-3 (IGFBP-3) is a p53 tumor suppressor-regulated
protein and a major carrier for IGFs in circulation. Among six high-affinity IGFBPs, which are …

Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer

R Morgan, K Hunter, HS Pandha - International journal of …, 2022 - Wiley Online Library
The HOX genes are a highly conserved group of transcription factors that have key roles in
early development, but which are also highly expressed in most cancers. Many studies have …

GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment

KH Song, MS Park, TS Nandu, S Gadad, SC Kim… - Nature …, 2016 - nature.com
Some polypeptide N-acetyl-galactosaminyltransferases (GALNTs) are associated with
cancer, but their function in organ-specific metastasis remains unclear. Here, we report that …

GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent manner

MS Park, AY Yang, JE Lee, SK Kim, J Roe, MS Park… - Cancer letters, 2021 - Elsevier
The deregulation of polypeptide N-acetyl-galactosaminyltransferases (GALNTs) contributes
to several cancers, but their roles in lung cancer remain unclear. In this study, we have …

HOX family transcription factors: Related signaling pathways and post-translational modifications in cancer

M Yu, J Zhan, H Zhang - Cellular signalling, 2020 - Elsevier
HOX family transcription factors belong to a highly conserved subgroup of the homeobox
superfamily that determines cellular fates in embryonic morphogenesis and the …

GALNT14: an emerging marker capable of predicting therapeutic outcomes in multiple cancers

WR Lin, CT Yeh - International journal of molecular sciences, 2020 - mdpi.com
Members of the polypeptide N-acetylgalactosaminyltransferase (GALNT) family function as
the initiating enzymes that catalyze mucin-type O-glycosylation of proteins, and their …

In silico drug repositioning: from large-scale transcriptome data to therapeutics

OS Kwon, W Kim, HJ Cha, H Lee - Archives of pharmacal research, 2019 - Springer
Drug repositioning is an attractive alternative to conventional drug development when new
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …

Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer

OS Kwon, H Lee, HJ Kong, EJ Kwon, JE Park, W Lee… - Oncogene, 2020 - nature.com
Despite the continual discovery of promising new cancer targets, drug discovery is often
hampered by the poor druggability of these targets. As such, repurposing FDA-approved …

HOX genes family and cancer: a novel role for homeobox B9 in the resistance to anti-angiogenic therapies

S Contarelli, V Fedele, D Melisi - Cancers, 2020 - mdpi.com
Simple Summary The inhibition of angiogenesis, relying on the use of drugs targeting the
VEGF signaling pathway, has become one of the main strategies for cancer treatment …

Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer

R Sheta, M Bachvarova, M Plante… - International …, 2017 - spandidos-publications.com
Protein glycosylation perturbations are implicated in a variety of diseases, including cancer.
Aberrant glycosylation in cancer is frequently attributed to altered expression of polypeptide …